Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Di Filippo, Massimiliano ^a   De Iure, Antonio ^a   Giampà, Carmela ^b   Chiasserini, Davide ^a   Tozzi, Alessandro ^a,b   Orvietani, Pier Luigi ^a   Ghiglieri, Veronica ^b   Tantucci, Michela ^a   Durante, Valentina ^a   Quiroga Varela, Ana ^a   Mancini, Andrea ^a   Costa, Cinzia ^a   Sarchielli, Paola ^a   Fusco, Francesca Romana ^b   Calabresi, Paolo ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL; ANIMAL BEHAVIOR; COGNITION; ENZYME ACTIVATION; ENZYMOLOGY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HIPPOCAMPAL CA1 REGION; LONG TERM POTENTIATION; METABOLISM; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; CA1 REGION, HIPPOCAMPAL; COGNITION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME ACTIVATION; FEMALE; LONG-TERM POTENTIATION; MICE; MICROGLIA; MULTIPLE SCLEROSIS; NADPH OXIDASE;

EID: 84959016597     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20926     Document Type: Article

References (41)

1. Compston, A., Coles, A. Multiple sclerosis. Lancet 372, 1502-1517 (2008).
2. Chiaravalloti, N. D., DeLuca, J. Cognitive impairment in multiple sclerosis. Lancet Neurol 7, 1139-1151 (2008).
3. Di Filippo, M., Sarchielli, P., Picconi, B., Calabresi, P. Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol Sci 29, 402-412 (2008).
4. Di Filippo, M. et al. Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Brain Res 1621, 205-213 (2014).
5. Novkovic, T., Shchyglo, O., Gold, R., Manahan-Vaughan, D. Hippocampal function is compromised in an animal model of multiple sclerosis. Neuroscience 309, 100-112 (2015).
6. Sicotte, N. L. et al. Regional hippocampal atrophy in multiple sclerosis. Brain 131, 1134-1141 (2008).
7. Di Filippo, M. et al. Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiol Dis 52, 229-236 (2013).
8. Chen, X. et al. The prospects of minocycline in multiple sclerosis. J Neuroimmunol 235, 1-8 (2011).
9. Lemon, N., Manahan-Vaughan, D. Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression. J Neurosci 26, 7723-7729 (2006).
10. Salter, M. W., Beggs, S. Sublime microglia: expanding roles for the guardians of the CNS. Cell 158, 15-24 (2014).
11. Surace, M. J., Block, M. L. Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors. Cell Mol Life Sci 69, 2409-2427 (2012).
12. Gao, H. M., Zhou, H., Hong, J. S. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Pharmacol Sci 33, 295-303 (2012).
13. Vereker, E., O'Donnell, E., Lynch, M. A. The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J Neurosci 20, 6811-6819 (2000).
14. Wake, H., Moorhouse, A. J., Miyamoto, A., Nabekura, J. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci 36, 209-217 (2013).
15. Miller, D. M. et al. A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations. Mult Scler 6, 267-273 (2000).
16. Foong, J. et al. Neuropsychological deficits in multiple sclerosis after acute relapse. J Neurol Neurosurg Psychiatry 64, 529-532 (1998).
17. Bellmann-Strobl, J. et al. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis. Neurology 73, 1624-1627 (2009).
18. Jones, M. W., McHugh, T. J. Updating hippocampal representations: CA2 joins the circuit. Trends Neurosci 34, 526-535 (2011).
19. Longoni, G. et al. Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS. Brain Struct Funct 220, 435-444 (2013).
20. Muhlert, N. et al. Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. J Neurol Neurosurg Psychiatry 85, 833-839 (2014).
21. Tong, L. et al. Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1beta via p38 mitogenactivated protein kinase. J Neurosci 32, 17714-17724 (2012).
22. Amato, M. P. et al. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler 16, 1474-1482 (2010).
23. Shankar, G. M. et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837-842 (2008).
24. Calabresi, P., Picconi, B., Parnetti, L., Di Filippo, M. A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol 5, 974-983 (2006).
25. Dutra, R. C. et al. Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of kallikrein-kinin system. Brain Behav Immun 33, 90-101 (2013).
26. Schafer, D. P. et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74, 691-705 (2012).
27. Paolicelli, R. C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456-1458 (2011).
28. Parkhurst, C. N. et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155, 1596-1609 (2013).
29. Griffin, R. et al. The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem 99, 1263-1272 (2006).
30. Liu, X., Wu, Z., Hayashi, Y., Nakanishi, H. Age-dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammation. Neuroscience 216, 133-142 (2012).
31. Bie, B. et al. Epigenetic suppression of neuroligin 1 underlies amyloid-induced memory deficiency. Nat Neurosci 17, 223-231 (2014).
32. Ziehn, M. O. et al. Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease. J Neurosci 32, 12312-12324 (2012).
33. Kamsler, A., Segal, M. Hydrogen peroxide modulation of synaptic plasticity. J Neurosci 23, 269-276 (2003).
34. Fischer, M. T. et al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135, 886-899 (2012).
35. Mander, P. K., Jekabsone, A., Brown, G. C. Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase. J Immunol 176, 1046-1052 (2006).
36. Bachstetter, A. D. et al. Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathology. J Neurosci 32, 10201-10210 (2012).
37. Amor, S., Smith, P. A., Hart, B., Baker, D. Biozzi mice: of mice and human neurological diseases. J Neuroimmunol 165, 1-10 (2005).
38. Al-Izki, S., P. G., O'Neill, J. K., Butter, C., Giovannoni, G., Baker, D. Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. Mult. Scler. Relat. Dis. 1, 29-38 (2012).
39. Costa, C. et al. Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. Brain 135, 1884-1899 (2012).
40. Kemp, A., Manahan-Vaughan, D. The hippocampal CA1 region and dentate gyrus differentiate between environmental and spatial feature encoding through long-term depression. Cereb Cortex 18, 968-977 (2008).
41. Sarchielli, P. et al. Immunological profile of silent brain infarction and lacunar stroke. PLoS One 8, e68428 (2013).